Cocrystal Pharma Reports Financial Results and Updates on Antiviral Drug-Development ProgramsOn November 13, 2024, Cocrystal Pharma, Inc. (NASDAQ: COCP) provided an overview of its financial results for the third quarter of 2024 and delivered updates
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Cocrystal Pharma’s 8K filing here. Cocrystal Pharma Company Profile (Get Free Report) Cocrystal Pharma, Inc, a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic […]
More Stories
Blue Wave or Broken Count? The 2026 Midterms and the Case for Prosecuting Election Fraud
By Stephen Zogopoulos, USNN World News The 2026 midterms produced a decisive Democratic wave. Democrats flipped the Senate by a...
McDonald’s US Sales Slip as Lower Traffic Offsets Higher Customer Spending
By Bill Pan McDonald’s reported mixed third-quarter results as fewer visits to its U.S. restaurants outweighed higher spending per customer....
Dow Jones Rises More Than 1,000 Points as Wall Street Digests Midterm Results
By Andrew Moran U.S. stocks surged midweek as Wall Street digested the Democratic Party’s decisive midterm victory. The blue-chip Dow...
Navy Admiral Removed by Hegseth Flips South Carolina Seat Held by Nancy Mace
By Zachary Stieber A retired U.S. Navy admiral, removed by the Pentagon in 2025, has won a Republican-held House seat...
Data Centers Are Losing 38-1 at the Ballot Box With More to Count
By Jeremy Lott Data center developers are having a bad year at ballot boxes across America. On Nov. 3, many...
Multiple Bomb Threats Made Against Flights Across Europe for 2nd Time This Week
By Guy Birchall Multiple flights across Europe received bomb threats on Thursday, marking the second time this week air travel...